VanEck Associates’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

VanEck Associates’s Portfolio ONXX Stock Details ONXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-156,354	Closed	-$19.5M	–	707
2013 Q3	$19.5M	Buy	156,354 +7,121	+5%	+$902K	0.1%	110
2013 Q2	$13M	Buy	+149,233	New	+$13.7M	0.07%	131

VanEck Associates's ONXX Position: Q4 2013 in Review

VanEck Associates sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 156,354 shares — an estimated $19.5M sold.

VanEck Associates first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $19.5M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

VanEck Associates reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
VanEck Associates sold 156,354 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $19.5M.
VanEck Associates first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
VanEck Associates's ONYX PHARMACEUTICALS INC position peaked at $19.5M in Q3 2013.
0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on VanEck Associates's 13F filing for Q4 2013, filed 12 Feb 2014.